share_log

iBio Inc | 4: Statement of changes in beneficial ownership of securities-Officer Duran Felipe

iBio Inc | 4: Statement of changes in beneficial ownership of securities-Officer Duran Felipe

iBio Inc | 4：持股變動聲明-高管 Duran Felipe
美股sec公告 ·  05/14 04:34
牛牛AI助理已提取核心訊息
Felipe Duran, the Chief Financial Officer of iBio Inc (IBIO.US), was involved in a transaction with the company's stock on May 9, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
Felipe Duran, the Chief Financial Officer of iBio Inc (IBIO.US), was involved in a transaction with the company's stock on May 9, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
iBio Inc（IBIO.US）的首席財務官費利佩·杜蘭於2024年5月9日參與了該公司股票的交易。公告中未披露交易的具體細節，例如行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量。這些信息對於投資者了解交易對其投資決策的影響至關重要。
iBio Inc（IBIO.US）的首席財務官費利佩·杜蘭於2024年5月9日參與了該公司股票的交易。公告中未披露交易的具體細節，例如行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量。這些信息對於投資者了解交易對其投資決策的影響至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。